These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6100430)

  • 1. Comparative in vitro activity of ceftriaxone against anaerobic bacteria.
    Rolfe RD; Finegold SM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):338-41. PubMed ID: 6100430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
    Jones RN; Barry AL; Aldridge KE; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds.
    Pollock HM; Holt J; Murray C
    Antimicrob Agents Chemother; 1983 May; 23(5):780-3. PubMed ID: 6307137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics.
    Ginunas VJ; Canawati HN; Sapico FL
    Clin Ther; 1984; 6(4):457-60. PubMed ID: 6467279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.
    Beskid G; Christenson JG; Cleeland R; DeLorenzo W; Trown PW
    Antimicrob Agents Chemother; 1981 Aug; 20(2):159-67. PubMed ID: 6269487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
    Rolfe RD; Finegold SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of anaerobic bacteria to antimicrobial agents.
    Collignon PJ; Munro R; Morris G
    Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V; Bismuth R; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of HR810 against 419 strict anaerobic bacteria.
    Jones RN; Gerlach EH
    Antimicrob Agents Chemother; 1985 Mar; 27(3):413-5. PubMed ID: 3994351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of imipenem against gram-positive anaerobic bacteria.
    Dubreuil L; Devos J; Romond C
    Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
    Del Bene VE; Carek PJ; Twitty JA; Burkey LJ
    Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative activity of 9 beta-lactamines, clindamycin and metronidazole on strictly anaerobic bacteria].
    Derriennic M; Reynaud A; Launay C; Courtieu AL
    Pathol Biol (Paris); 1987 May; 35(5):572-6. PubMed ID: 3302862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
    Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
    Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
    Aldridge KE; Johnson WD
    J Antimicrob Chemother; 1997 Mar; 39(3):319-24. PubMed ID: 9096180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.
    Edmiston CE; Krepel CJ; Clausz JC; Condon RE
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):105-13. PubMed ID: 3164263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Owens WE; Finegold SM
    Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria.
    Obaseiki-Ebor EE; Afonya TC; Oyaide SM
    Chemotherapy; 1985; 31(2):130-7. PubMed ID: 3872779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.